BioInteractions has announced the launch of Surface-Active Systems (SAS), a pioneering new category of high-performance, zero-leaching coating solutions designed to improve implant performance, enhance patient safety, and evolve therapeutic outcomes.
Comprising both Surface-Active Therapeutics (SAT) and Surface-Active Materials (SAM), Surface-Active Systems address the rising demands in infection prevention, thrombosis control and device longevity across a growing range of minimally invasive and long-term implantable…